B. Tawfik

发表

Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML).

S. Isom, B. Powell, T. Pardee, 2016, Journal of geriatric oncology.

Developing a survivorship care plan (SCP) delivery process for patients and primary care providers serving poor, rural, and minority patients with cancer

C. Wiggins, I. S. Gil, S. Gagnon, 2021, Supportive Care in Cancer.

Costs of treatment change following first-line somatostatin analog monotherapy among patients with neuroendocrine tumors

N. Princic, B. Tawfik, M. Moynihan, 2021, Journal of medical economics.

House Officer–Driven Reduction in Laboratory Utilization

David P. Miller, N. Fino, B. Tawfik, 2016, Southern medical journal.

Reaching the “Hard-to-Reach” Sexual and Gender Diverse Communities for Population-Based Research in Cancer Prevention and Control: Methods for Online Survey Data Collection and Management

P. Madhivanan, Shiraz I Mishra, Miria Kano, 2022, Frontiers in Oncology.

Association between glycemic control, age, and outcomes among intensively treated patients with acute myeloid leukemia

S. Isom, B. Powell, T. Pardee, 2018, Supportive Care in Cancer.

Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies

Weina Chen, Shuang Niu, N. Sadeghi, 2018, Annals of Hematology.

Patient, provider, and nurse preferences of patient reported outcomes (PRO) and side effect management during cancer treatment of underrepresented racial and ethnic minority groups, rural and economically disadvantaged patients: a mixed methods study

U. Brown-Glaberman, D. Guest, E. Burgess, 2022, Cancer Causes & Control.

Re-induction therapy in adult patients with acute myeloid leukemia with ≤20 % blasts: A retrospective cohort study.

D. Howard, B. Powell, T. Pardee, 2021, Leukemia research.

Reply to T. Shimoi et al and Y. Shimanuki et al.

W. Symmans, A. Wolff, A. DeMichele, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bevacizumab-Induced Bowel Perforation

B. Tawfik, S. Sliesoraitis, 2011, The Journal of the American Osteopathic Association.

Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131

W. Symmans, A. Wolff, A. DeMichele, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The neutrophil to albumin ratio as a predictor of pathological complete response in rectal cancer patients following neoadjuvant chemoradiation

A. Mokdad, S. Huerta, Prachi M. Patel, 2016, Anti-cancer drugs.

Pharmacist-Driven Oral Oncolytic Medication Education and Consent.

R. Lauer, Z. Dayao, N. Hashemi, 2019, JCO oncology practice.

Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML)

S. Isom, B. Powell, T. Pardee, 2013, Annals of Hematology.

Ischemic stroke in a patient with moderate to severe inherited factor VII deficiency.

Manasa S. Reddy, R. Sarode, S. Hofmann, 2016, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

The RPL/RPS Gene Signature of Melanoma CTCs Associates with Brain Metastasis

Yan Guo, B. Fahy, I. Lagutina, 2022, Cancer research communications.

Phase II trial of ribociclib and everolimus in p16 low anaplastic thyroid cancer (ATC).

T. Strom, D. Gerber, B. Burtness, 2017 .

Developing Questions to Assess and Measure Patients’ Perceived Survival Benefit from Adjuvant Endocrine Therapy in Breast Cancer: A Mixed Methods Pilot Study

U. Brown-Glaberman, D. Guest, A. Sussman, 2023, Research square.